Viewing Study NCT01205035

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:03 PM
Ignite Modification Date: 2026-05-03 @ 3:14 PM
Study NCT ID: NCT01205035
Status: COMPLETED
Last Update Posted: 2015-04-10
First Post: 2010-09-16
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia
Sponsor: Eye Center of Northern Colorado, P.C.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Retinal Diseases View
None Telangiectasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Idiopathic Parafoveal Telangiectasia View
None Macular Telangiectasia View
None Macula Lutea/pathology View
None Retinal Diseases/pathology View
None Retinal Pigments/metabolism View
None Telangiectasis/metabolism View
None Telangiectasis/pathology View